New Crowdin updates

docs/CROWDIN/cs/Getting-Started/Introduction.md

@@ -102,7 +102,7 @@ S **AAPS** je snadné sledovat věci jako: množství inzulínu v pumpě, stář
 **AAPS** je zcela transparentní, logický a předvídatelný algoritmus, což může usnadnit rozpoznání špatného nastavení a odpovídajícím způsobem jej upravit. Přesně vidíte, co systém dělá a proč to dělá. Natavením provozních limitů bude kontrola (a odpovědnost) ve vašich rukou. To může uživateli poskytnout důvěru a klidný spánek.
 
 #### 11) **Access to advanced features through development (dev) modes including full closed loop**
-Tato dokumentace **AAPS** se zaměřuje na hlavní - nejstandardnější - **„master“** větev **AAPS**. Výzkum a vývoj však stále pokračuje. Zkušenější uživatelé mohou zkoušet objevovat experimentální funkce v **vývojové větvi**. To zahrnuje integraci senzoru Dexcom G7 a automatickou úpravu dodávky inzulinu podle krátkodobých změn citlivosti (DYNISF). Inovace v oblasti rozvoje se zaměřují na strategie pro úplnou uzavřenou smyčku (zcela bez bolusování k jídlu _apod._) a obecně se snaží o co nejpohodlnější život s diabetem 1. typu.
+Tato dokumentace **AAPS** se zaměřuje na hlavní - nejstandardnější - **„master“** větev **AAPS**. Výzkum a vývoj však stále pokračuje. Zkušenější uživatelé mohou zkoušet objevovat experimentální funkce v **vývojové větvi**. Inovace v oblasti rozvoje se zaměřují na strategie pro úplnou uzavřenou smyčku (zcela bez bolusování k jídlu _apod._) a obecně se snaží o co nejpohodlnější život s diabetem 1. typu.
 
 #### 12) **Ability to contribute yourself to further improvements**
 Diabetes typu 1 může být velmi frustrující a můžete mít pocit, že jste na to sami. Získání kontroly nad vlastní technikou pro zvládání diabetu s možností "splacení" formou pomoci ostatním, jak se postupně zlepšujete, může být velmi obohacující. Můžete se sami vzdělávat a rozvíjet, objevovat a vyhledávat překážky a dokonce přispívat k novému vývoji a dokumentaci. Cestou potkáte další lidi se stejným cílem, se kterými můžete sdílet nápady a pracovat na nich společně. Tohle je podstata #WeAreNotWaiting.

docs/CROWDIN/de/Getting-Started/Introduction.md

@@ -102,7 +102,7 @@ Kein automatisiertes Insulinsystem ist perfekt. Kommerzielle und Open-Source-Sys
 **AAPS** ist völlig transparent, logisch und berechenbar was es einfacher machen kann zu wissen, wann eine Einstellung falsch ist, und sie entsprechend anzupassen. Du kannst zu jeder Zeit genau sehen, was das System tut, warum es das tut und die Kontrolle wieder in Deine Hand nehmen, indem Du entsprechende Grenzen setzt. Dies schafft Vertrauen und Dir einen erholsameren Schlaf.
 
 #### 11) **Zugriff auf erweiterte Funktionen durch Entwicklungsmodi (dev) einschließlich vollständigem Closed Loop**
-Diese **AAPS** Dokumentation konzentriert sich auf die Hauptentwicklung im **“master”**-Branch [in Git] von **AAPS**. Forschung und Entwicklung laufen jedoch ständig. Erfahrene Benutzer können die experimentellen Funktionen im **"development"**-Branch erkunden. Dazu gehört die Integration von Dexcom G7 und die automatische Anpassung der Insulinlieferung an kurzfristige Sensibilitätsänderungen (DYNISF). Die Neuentwicklungen konzentrieren sich auf Strategien zum vollständigen Closed Loop (ohne Bolus für Mahlzeiten _usw._) und versuchen ganz allgemein, das Leben mit Typ-1-Diabetes so angenehm wie möglich zu machen.
+Diese **AAPS** Dokumentation konzentriert sich auf die Hauptentwicklung im **“master”**-Branch [in Git] von **AAPS**. Forschung und Entwicklung laufen jedoch ständig. Erfahrene Benutzer können die experimentellen Funktionen im **"development"**-Branch erkunden. Die Neuentwicklungen konzentrieren sich auf Strategien zum vollständigen Closed Loop (ohne Bolus für Mahlzeiten _usw._) und versuchen ganz allgemein, das Leben mit Typ-1-Diabetes so angenehm wie möglich zu machen.
 
 #### 12) **Möglichkeit, sich an weiteren Verbesserungen zu beteiligen**
 Diabetes Typ 1 kann sehr frustrierend sein und dazu führen, dass Du Dich alleingelassen fühlst. Seine Diabetes-Technolgie selber unter Kontrolle zu haben und etwas an die Community zurückzugeben ("pay it forward") indem Du andere bei deren Reise unterstützst, kann ein gutes und befriedigendes Gefühl geben. Du kannst Dich selbst weiterbilden, Hindernisse erkennen und auch Deine Beiträge zur Weiterentwicklung und/oder zur Dokumentation leisten. In der Community gibt es andere, die das gleiche Ziel haben und mit denen Du Ideen austauschen und zusammenarbeiten kannst. Dies ist die Grundidee und der Geist von #WeAreNotWaiting.

docs/CROWDIN/el/Getting-Started/Introduction.md

@@ -102,7 +102,7 @@ No automated insulin delivery system is perfect. Commercial and open-source syst
 **AAPS** is totally transparent, logical and predictable, which may make it easier to know when a setting is wrong, and to adjust it accordingly. You can see exactly what the system is doing, why it is doing it, and set its operational limits, which puts the control (and responsibility) in your hands. This can provide the user with confidence, and a sounder sleep.
 
 #### 11) **Access to advanced features through development (dev) modes including full closed loop**
-This **AAPS** documentation focuses on the mainstream **“master”** branch of **AAPS**. However, research and development is going on all the time. More experienced users may wish to explore the experimental features in the **development** branch. This includes integration of Dexcom G7, and automatically adjusting insulin delivery according to short-term sensitivity changes (DYNISF). The development innovations focus on strategies for full closed looping (not having to bolus for meals _etc._), and generally trying to make life with type 1 diabetes as convenient as possible.
+This **AAPS** documentation focuses on the mainstream **“master”** branch of **AAPS**. However, research and development is going on all the time. More experienced users may wish to explore the experimental features in the **development** branch. The development innovations focus on strategies for full closed looping (not having to bolus for meals _etc._), and generally trying to make life with type 1 diabetes as convenient as possible.
 
 #### 12) **Ability to contribute yourself to further improvements**
 Type 1 diabetes can be highly frustrating and isolating. Having control over your own diabetes tech, with the possibility to “pay it forward” as soon as you are making progress by helping others on their journey can be really rewarding. You can educate yourself, discover the roadblocks and look for, and even contribute, to new developments and the documentation. There will be others in the community with the same quest that you can bounce ideas off and work with. This is the essence of #WeAreNotWaiting.

docs/CROWDIN/es/Getting-Started/Introduction.md

@@ -102,7 +102,7 @@ No automated insulin delivery system is perfect. Los sistemas comerciales y de c
 **AAPS** is totally transparent, logical and predictable, which may make it easier to know when a setting is wrong, and to adjust it accordingly. Puedes ver exactamente lo que el sistema está haciendo, por qué lo está haciendo y establecer sus límites operativos, lo que coloca el control (y la responsabilidad) en tus manos. Esto puede brindar al usuario confianza y un sueño más tranquilo.
 
 #### 11) **Access to advanced features through development (dev) modes including full closed loop**
-This **AAPS** documentation focuses on the mainstream **“master”** branch of **AAPS**. However, research and development is going on all the time. More experienced users may wish to explore the experimental features in the **development** branch. This includes integration of Dexcom G7, and automatically adjusting insulin delivery according to short-term sensitivity changes (DYNISF). The development innovations focus on strategies for full closed looping (not having to bolus for meals _etc._), and generally trying to make life with type 1 diabetes as convenient as possible.
+This **AAPS** documentation focuses on the mainstream **“master”** branch of **AAPS**. However, research and development is going on all the time. More experienced users may wish to explore the experimental features in the **development** branch. The development innovations focus on strategies for full closed looping (not having to bolus for meals _etc._), and generally trying to make life with type 1 diabetes as convenient as possible.
 
 #### 12) **Ability to contribute yourself to further improvements**
 Type 1 diabetes can be highly frustrating and isolating. Tener el control sobre tu propia tecnología para la diabetes, con la posibilidad de "retribuir" tan pronto como haces progresos al ayudar a otros en su camino, puede ser realmente gratificante. You can educate yourself, discover the roadblocks and look for, and even contribute, to new developments and the documentation. There will be others in the community with the same quest that you can bounce ideas off and work with. Esta es la esencia de #WeAreNotWaiting.

docs/CROWDIN/fr/Getting-Started/Introduction.md

@@ -102,7 +102,7 @@ Aucun système d'administration d'insuline automatique n'est parfait. Les systè
 **AAPS** est totalement transparent, logique et prévisible, ce qui peut faciliter la compréhension lorsque qu'un paramètre est incorrect et permet de l'ajuster en conséquence. Vous pouvez voir exactement ce que fait le système, pourquoi il le fait, et définissez ses limites opérationnelles, ce qui met le contrôle (et la responsabilité) entre vos mains. L'utilisateur peut gagner en assurance et bénéficier d'un sommeil plus tranquille.
 
 #### 11) **Accès à des fonctionnalités avancées via les modes de développement (dev), y compris la boucle fermée complète**
-Cette documentation **AAPS** se concentre sur la branche principale **“master”** de **AAPS**. Cependant, la recherche et le développement n'arrêtent jamais. Les utilisateurs plus expérimentés peuvent souhaiter explorer les fonctionnalités expérimentales dans la branche de **développement**. Cela inclut l'intégration du Dexcom G7 et l'ajustement automatique de l'injection d'insuline en fonction des changements de sensibilité à court terme (DYNISF). Les innovations en matière de développement se concentrent sur des stratégies de boucle fermée totale (sans avoir à saisir de bolus pour les repas _etc._), et essayent de manière générale de rendre la vie avec le diabète de type 1 aussi facile que possible.
+Cette documentation **AAPS** se concentre sur la branche principale **“master”** de **AAPS**. Cependant, la recherche et le développement n'arrêtent jamais. Les utilisateurs plus expérimentés peuvent souhaiter explorer les fonctionnalités expérimentales dans la branche de **développement**. Les innovations en matière de développement se concentrent sur des stratégies de boucle fermée totale (sans avoir à saisir de bolus pour les repas _etc._), et essayent de manière générale de rendre la vie avec le diabète de type 1 aussi facile que possible.
 
 #### 12) **Possibilité de contribuer vous-même à l'ajout de nouvelles fonctionnalités**
 Le diabète de type 1 peut être très frustrant et isole les personnes. Avoir le contrôle de votre propre système technologique pour votr diabète, avec la possibilité de contribuer à votre tour dès que vous faites des progrès en aidant les autres dans leur cheminement peut être vraiment gratifiant. Vous pouvez vous former, mettre au jour des obstacles, faire des recherches et même contribuer à de nouveaux développements et à la documentation. Vous trouverez d'autres personnes dans la communauté avec qui partager la même envie de progresser, avec qui réfléchir et travailler. C'est l'essence même du mouvement #WeAreNotWaiting.

docs/CROWDIN/he/Getting-Started/Introduction.md

@@ -102,7 +102,7 @@ No automated insulin delivery system is perfect. Commercial and open-source syst
 **AAPS** is totally transparent, logical and predictable, which may make it easier to know when a setting is wrong, and to adjust it accordingly. You can see exactly what the system is doing, why it is doing it, and set its operational limits, which puts the control (and responsibility) in your hands. This can provide the user with confidence, and a sounder sleep.
 
 #### 11) **Access to advanced features through development (dev) modes including full closed loop**
-This **AAPS** documentation focuses on the mainstream **“master”** branch of **AAPS**. However, research and development is going on all the time. More experienced users may wish to explore the experimental features in the **development** branch. This includes integration of Dexcom G7, and automatically adjusting insulin delivery according to short-term sensitivity changes (DYNISF). The development innovations focus on strategies for full closed looping (not having to bolus for meals _etc._), and generally trying to make life with type 1 diabetes as convenient as possible.
+This **AAPS** documentation focuses on the mainstream **“master”** branch of **AAPS**. However, research and development is going on all the time. More experienced users may wish to explore the experimental features in the **development** branch. The development innovations focus on strategies for full closed looping (not having to bolus for meals _etc._), and generally trying to make life with type 1 diabetes as convenient as possible.
 
 #### 12) **Ability to contribute yourself to further improvements**
 Type 1 diabetes can be highly frustrating and isolating. Having control over your own diabetes tech, with the possibility to “pay it forward” as soon as you are making progress by helping others on their journey can be really rewarding. You can educate yourself, discover the roadblocks and look for, and even contribute, to new developments and the documentation. There will be others in the community with the same quest that you can bounce ideas off and work with. This is the essence of #WeAreNotWaiting.

docs/CROWDIN/ko/Getting-Started/Introduction.md

@@ -102,7 +102,7 @@ No automated insulin delivery system is perfect. Commercial and open-source syst
 **AAPS** is totally transparent, logical and predictable, which may make it easier to know when a setting is wrong, and to adjust it accordingly. You can see exactly what the system is doing, why it is doing it, and set its operational limits, which puts the control (and responsibility) in your hands. This can provide the user with confidence, and a sounder sleep.
 
 #### 11) **Access to advanced features through development (dev) modes including full closed loop**
-This **AAPS** documentation focuses on the mainstream **“master”** branch of **AAPS**. However, research and development is going on all the time. More experienced users may wish to explore the experimental features in the **development** branch. This includes integration of Dexcom G7, and automatically adjusting insulin delivery according to short-term sensitivity changes (DYNISF). The development innovations focus on strategies for full closed looping (not having to bolus for meals _etc._), and generally trying to make life with type 1 diabetes as convenient as possible.
+This **AAPS** documentation focuses on the mainstream **“master”** branch of **AAPS**. However, research and development is going on all the time. More experienced users may wish to explore the experimental features in the **development** branch. The development innovations focus on strategies for full closed looping (not having to bolus for meals _etc._), and generally trying to make life with type 1 diabetes as convenient as possible.
 
 #### 12) **Ability to contribute yourself to further improvements**
 Type 1 diabetes can be highly frustrating and isolating. Having control over your own diabetes tech, with the possibility to “pay it forward” as soon as you are making progress by helping others on their journey can be really rewarding. You can educate yourself, discover the roadblocks and look for, and even contribute, to new developments and the documentation. There will be others in the community with the same quest that you can bounce ideas off and work with. This is the essence of #WeAreNotWaiting.

docs/CROWDIN/lt/Getting-Started/Introduction.md

@@ -102,7 +102,7 @@ No automated insulin delivery system is perfect. Commercial and open-source syst
 **AAPS** is totally transparent, logical and predictable, which may make it easier to know when a setting is wrong, and to adjust it accordingly. You can see exactly what the system is doing, why it is doing it, and set its operational limits, which puts the control (and responsibility) in your hands. This can provide the user with confidence, and a sounder sleep.
 
 #### 11) **Access to advanced features through development (dev) modes including full closed loop**
-This **AAPS** documentation focuses on the mainstream **“master”** branch of **AAPS**. However, research and development is going on all the time. More experienced users may wish to explore the experimental features in the **development** branch. This includes integration of Dexcom G7, and automatically adjusting insulin delivery according to short-term sensitivity changes (DYNISF). The development innovations focus on strategies for full closed looping (not having to bolus for meals _etc._), and generally trying to make life with type 1 diabetes as convenient as possible.
+This **AAPS** documentation focuses on the mainstream **“master”** branch of **AAPS**. However, research and development is going on all the time. More experienced users may wish to explore the experimental features in the **development** branch. The development innovations focus on strategies for full closed looping (not having to bolus for meals _etc._), and generally trying to make life with type 1 diabetes as convenient as possible.
 
 #### 12) **Ability to contribute yourself to further improvements**
 Type 1 diabetes can be highly frustrating and isolating. Having control over your own diabetes tech, with the possibility to “pay it forward” as soon as you are making progress by helping others on their journey can be really rewarding. You can educate yourself, discover the roadblocks and look for, and even contribute, to new developments and the documentation. There will be others in the community with the same quest that you can bounce ideas off and work with. This is the essence of #WeAreNotWaiting.